Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Evaluation of epigallocatechin-3-gallate (EGCG) modified collagen in guided bone regeneration (GBR) surgery and modulation of macrophage phenotype.

Chu C, Wang Y, Wang Y, Yang R, Liu L, Rung S, Xiang L, Wu Y, Du S, Man Y, Qu Y.

Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:73-82. doi: 10.1016/j.msec.2019.01.083. Epub 2019 Jan 21.

PMID:
30889747
2.

Macrophage phenotype in the epigallocatechin-3-gallate (EGCG)-modified collagen determines foreign body reaction.

Chu C, Liu L, Wang Y, Wei S, Wang Y, Man Y, Qu Y.

J Tissue Eng Regen Med. 2018 Jun;12(6):1499-1507. doi: 10.1002/term.2687. Epub 2018 May 15.

PMID:
29704322
3.

Evaluation of nanohydroxyapaptite (nano-HA) coated epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes.

Chu C, Deng J, Man Y, Qu Y.

Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:258-264. doi: 10.1016/j.msec.2017.04.069. Epub 2017 Apr 18.

PMID:
28575983
4.

Evaluation of epigallocatechin-3-gallate (EGCG)-modified scaffold determines macrophage recruitment.

Chu C, Liu L, Wang Y, Yang R, Hu C, Rung S, Man Y, Qu Y.

Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:505-513. doi: 10.1016/j.msec.2019.03.007. Epub 2019 Mar 3.

PMID:
30948087
5.

Evaluation of epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes and concerns on osteoblasts.

Chu C, Deng J, Xiang L, Wu Y, Wei X, Qu Y, Man Y.

Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:386-394. doi: 10.1016/j.msec.2016.05.021. Epub 2016 May 7.

PMID:
27287135
6.

Application of PEG and EGCG modified collagen-base membrane to promote osteoblasts proliferation.

Chu C, Deng J, Hou Y, Xiang L, Wu Y, Qu Y, Man Y.

Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:31-36. doi: 10.1016/j.msec.2017.02.157. Epub 2017 Feb 28.

PMID:
28482532
7.

The osteoimmunomodulatory property of a barrier collagen membrane and its manipulation via coating nanometer-sized bioactive glass to improve guided bone regeneration.

Chen Z, Chen L, Liu R, Lin Y, Chen S, Lu S, Lin Z, Chen Z, Wu C, Xiao Y.

Biomater Sci. 2018 May 1;6(5):1007-1019. doi: 10.1039/c7bm00869d.

PMID:
29485658
8.

Evaluation of 3D printed PCL/PLGA/β-TCP versus collagen membranes for guided bone regeneration in a beagle implant model.

Won JY, Park CY, Bae JH, Ahn G, Kim C, Lim DH, Cho DW, Yun WS, Shim JH, Huh JB.

Biomed Mater. 2016 Oct 7;11(5):055013.

PMID:
27716630
9.

[Effect of epigallocatechin-3-gallate on the proliferation and osteogenesis of human periodontal ligament cells].

Liu J, Lu Y, Wang ZZ, Du WZ, Pei DD.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2016 Dec 9;51(12):758-764. doi: 10.3760/cma.j.issn.1002-0098.2016.12.011. Chinese.

PMID:
27978918
10.

Effects of Epigallocatechin Gallate, an Antibacterial Cross-linking Agent, on Proliferation and Differentiation of Human Dental Pulp Cells Cultured in Collagen Scaffolds.

Kwon YS, Kim HJ, Hwang YC, Rosa V, Yu MK, Min KS.

J Endod. 2017 Feb;43(2):289-296. doi: 10.1016/j.joen.2016.10.017.

PMID:
28132713
11.

Evaluation of Epigallocatechin-3-gallate Modified Collagen Membrane and Concerns on Schwann Cells.

Chu C, Deng J, Cao C, Man Y, Qu Y.

Biomed Res Int. 2017;2017:9641801. doi: 10.1155/2017/9641801. Epub 2017 Aug 15.

13.

Osteoblast proliferation and differentiation on a barrier membrane in combination with BMP2 and TGFβ1.

Miron RJ, Saulacic N, Buser D, Iizuka T, Sculean A.

Clin Oral Investig. 2013 Apr;17(3):981-8. doi: 10.1007/s00784-012-0764-7. Epub 2012 Jun 6.

PMID:
22669486
14.

EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Qiu Y, Chen Y, Zeng T, Guo W, Zhou W, Yang X.

Mol Biol Rep. 2016 Mar;43(3):183-93. doi: 10.1007/s11033-015-3936-0. Epub 2016 Jan 16.

PMID:
26780211
15.

Epigallocatechin Gallate-Modified Gelatin Sponges Treated by Vacuum Heating as a Novel Scaffold for Bone Tissue Engineering.

Honda Y, Takeda Y, Li P, Huang A, Sasayama S, Hara E, Uemura N, Ueda M, Hashimoto M, Arita K, Matsumoto N, Hashimoto Y, Baba S, Tanaka T.

Molecules. 2018 Apr 11;23(4). pii: E876. doi: 10.3390/molecules23040876.

16.

Comparative analysis of collagen membranes for the treatment of implant dehiscence defects.

Oh TJ, Meraw SJ, Lee EJ, Giannobile WV, Wang HL.

Clin Oral Implants Res. 2003 Feb;14(1):80-90.

17.

Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.

Jin P, Wu H, Xu G, Zheng L, Zhao J.

Cell Tissue Res. 2014 May;356(2):381-90. doi: 10.1007/s00441-014-1797-9. Epub 2014 Mar 29.

PMID:
24682582
18.

Nature-derived epigallocatechin gallate/duck's feet collagen/hydroxyapatite composite sponges for enhanced bone tissue regeneration.

Kook YJ, Tian J, Jeon YS, Choi MJ, Song JE, Park CH, Reis RL, Khang G.

J Biomater Sci Polym Ed. 2018 May - Jun;29(7-9):984-996. doi: 10.1080/09205063.2017.1414480. Epub 2017 Dec 20.

PMID:
29207926
19.

Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.

Matsuzaki S, Darcha C.

Hum Reprod. 2014 Aug;29(8):1677-87. doi: 10.1093/humrep/deu123. Epub 2014 May 29.

PMID:
24876174
20.

The effects of ErhBMP-2-/EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs.

Shin YS, Seo JY, Oh SH, Kim JH, Kim ST, Park YB, Moon HS.

Oral Dis. 2014 Apr;20(3):281-7. doi: 10.1111/odi.12109. Epub 2013 May 7.

PMID:
23651333

Supplemental Content

Support Center